• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从术前到手术的基于血液的胶质瘤代谢标志物。

Blood based metabolic markers of glioma from pre-diagnosis to surgery.

机构信息

Department of Chemistry, Umeå University, Linnaeus väg 10, 901 87, Umeå, Sweden.

Department of Clinical Science, Neurosciences, Umeå University, 901 85, Umeå, Sweden.

出版信息

Sci Rep. 2024 Sep 5;14(1):20680. doi: 10.1038/s41598-024-71375-6.

DOI:10.1038/s41598-024-71375-6
PMID:39237693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11377417/
Abstract

Gliomas are highly complex and metabolically active brain tumors associated with poor prognosis. Recent reports have found altered levels of blood metabolites during early tumor development, suggesting that tumor development could be detected several years before clinical manifestation. In this study, we performed metabolite analyses of blood samples collected from healthy controls and future glioma patients, up to eight years before glioma diagnosis, and on the day of glioma surgery. We discovered that metabolites related to early glioma development were associated with an increased energy turnover, as highlighted by elevated levels of TCA-related metabolites such as fumarate, malate, lactate and pyruvate in pre-diagnostic cases. We also found that metabolites related to glioma progression at surgery were primarily high levels of amino acids and metabolites of amino acid catabolism, with elevated levels of 11 amino acids and two branched-chain alpha-ketoacids, ketoleucine and ketoisoleucine. High amino acid turnover in glioma tumor tissue is currently utilized for PET imaging, diagnosis and delineation of tumor margins. By examining blood-based metabolic progression patterns towards disease onset, we demonstrate that this high amino acid turnover is also detectable in a simple blood sample. These findings provide additional insight of metabolic alterations during glioma development and progression.

摘要

神经胶质瘤是高度复杂且代谢活跃的脑肿瘤,预后不良。最近的报告发现,在早期肿瘤发展过程中血液代谢物水平发生改变,这表明肿瘤的发展可能在临床症状出现前几年就被检测到。在这项研究中,我们对来自健康对照组和未来的神经胶质瘤患者的血液样本进行了代谢物分析,这些样本采集于神经胶质瘤诊断前长达八年的时间,并在神经胶质瘤手术当天进行了采集。我们发现,与早期神经胶质瘤发展相关的代谢物与能量代谢增加有关,这一点在预诊断病例中 TCA 相关代谢物(如富马酸、苹果酸、乳酸和丙酮酸)的水平升高中得到了体现。我们还发现,与手术时神经胶质瘤进展相关的代谢物主要是氨基酸水平升高和氨基酸分解代谢物升高,有 11 种氨基酸和两种支链α-酮酸(酮亮氨酸和酮异亮氨酸)水平升高。在神经胶质瘤肿瘤组织中,高氨基酸周转率目前用于 PET 成像、诊断和肿瘤边界的描绘。通过检查疾病发病前的基于血液的代谢进展模式,我们证明这种高氨基酸周转率在简单的血液样本中也能被检测到。这些发现为神经胶质瘤发展和进展过程中的代谢改变提供了更多的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/11377417/4211f426c108/41598_2024_71375_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/11377417/896d9ed19210/41598_2024_71375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/11377417/ee33eb0cd473/41598_2024_71375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/11377417/cf9edc3bbb8b/41598_2024_71375_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/11377417/c4947763424a/41598_2024_71375_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/11377417/4211f426c108/41598_2024_71375_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/11377417/896d9ed19210/41598_2024_71375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/11377417/ee33eb0cd473/41598_2024_71375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/11377417/cf9edc3bbb8b/41598_2024_71375_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/11377417/c4947763424a/41598_2024_71375_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/11377417/4211f426c108/41598_2024_71375_Fig5_HTML.jpg

相似文献

1
Blood based metabolic markers of glioma from pre-diagnosis to surgery.从术前到手术的基于血液的胶质瘤代谢标志物。
Sci Rep. 2024 Sep 5;14(1):20680. doi: 10.1038/s41598-024-71375-6.
2
Serum lactate levels are associated with glioma malignancy grade.血清乳酸水平与胶质瘤恶性程度相关。
Clin Neurol Neurosurg. 2019 Nov;186:105546. doi: 10.1016/j.clineuro.2019.105546. Epub 2019 Oct 1.
3
A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker.血清外泌体中的 microRNA 特征作为胶质细胞瘤患者的补充诊断生物标志物。
J Neurooncol. 2018 Jan;136(1):51-62. doi: 10.1007/s11060-017-2639-x. Epub 2017 Oct 26.
4
Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes.胶质瘤患者血浆样本中的代谢组学分析与肿瘤表型相关。
Oncotarget. 2016 Apr 12;7(15):20486-95. doi: 10.18632/oncotarget.7974.
5
Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas.术前和术后新诊断脑胶质瘤患者的血浆神经胶质纤维酸性蛋白水平。
J Neurooncol. 2012 Aug;109(1):123-7. doi: 10.1007/s11060-012-0874-8. Epub 2012 Apr 11.
6
The Role of Peripheral Inflammatory Markers and Coagulation Factors in Patients with Central Nervous System (CNS) Immune Disease and Glioma.外周炎症标志物和凝血因子在中枢神经系统(CNS)免疫疾病和神经胶质瘤患者中的作用。
World Neurosurg. 2024 Aug;188:e177-e193. doi: 10.1016/j.wneu.2024.05.080. Epub 2024 May 17.
7
Serum microRNA is a biomarker for post-operative monitoring in glioma.血清 microRNA 是胶质瘤术后监测的生物标志物。
J Neurooncol. 2020 Sep;149(3):391-400. doi: 10.1007/s11060-020-03566-w. Epub 2020 Sep 11.
8
Plasma miR-454-3p as a potential prognostic indicator in human glioma.血浆miR-454-3p作为人类胶质瘤潜在的预后指标。
Neurol Sci. 2015 Feb;36(2):309-13. doi: 10.1007/s10072-014-1938-7. Epub 2014 Sep 6.
9
Blood-based biomarkers for the diagnosis and monitoring of gliomas.用于诊断和监测脑胶质瘤的基于血液的生物标志物。
Neuro Oncol. 2018 Aug 2;20(9):1155-1161. doi: 10.1093/neuonc/noy074.
10
Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.来自脑脊液的miRNA - 21外泌体水平与胶质瘤患者的预后不良和肿瘤复发相关。
Oncotarget. 2015 Sep 29;6(29):26971-81. doi: 10.18632/oncotarget.4699.

引用本文的文献

1
From Biomarker Discovery to Clinical Applications of Metabolomics in Glioblastoma.从生物标志物发现到代谢组学在胶质母细胞瘤中的临床应用
Metabolites. 2025 Apr 29;15(5):295. doi: 10.3390/metabo15050295.
2
Amino acid metabolism in glioblastoma pathogenesis, immune evasion, and treatment resistance.氨基酸代谢在胶质母细胞瘤发病机制、免疫逃逸和治疗抗性中的作用
Cancer Cell Int. 2025 Mar 13;25(1):89. doi: 10.1186/s12935-025-03721-1.

本文引用的文献

1
Altered plasma metabolite levels can be detected years before a glioma diagnosis.血浆代谢物水平的改变可以在胶质母细胞瘤诊断前数年被检测到。
JCI Insight. 2023 Oct 9;8(19):e171225. doi: 10.1172/jci.insight.171225.
2
Prediagnostic biomarkers for early detection of glioma-using case-control studies from cohorts as study approach.利用队列中的病例对照研究作为研究方法,寻找用于早期检测胶质瘤的诊断前生物标志物。
Neurooncol Adv. 2022 Nov 11;4(Suppl 2):ii73-ii80. doi: 10.1093/noajnl/vdac036. eCollection 2022 Nov.
3
Rewired Metabolism of Amino Acids and Its Roles in Glioma Pathology.
氨基酸代谢重编程及其在胶质瘤病理中的作用
Metabolites. 2022 Sep 28;12(10):918. doi: 10.3390/metabo12100918.
4
An exercise-inducible metabolite that suppresses feeding and obesity.一种可诱导运动的代谢物,可抑制进食和肥胖。
Nature. 2022 Jun;606(7915):785-790. doi: 10.1038/s41586-022-04828-5. Epub 2022 Jun 15.
5
The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology.支链氨基酸(BCAAs)代谢调节酶,支链氨基酸转氨酶(BCAT)和支链α-酮酸脱氢酶(BCKD)在人类病理生理学中的关键作用。
Int J Mol Sci. 2022 Apr 5;23(7):4022. doi: 10.3390/ijms23074022.
6
A systematic review of amino acid PET in assessing treatment response to temozolomide in glioma.一项关于氨基酸正电子发射断层扫描(PET)评估胶质瘤对替莫唑胺治疗反应的系统评价。
Neurooncol Adv. 2022 Feb 13;4(1):vdac008. doi: 10.1093/noajnl/vdac008. eCollection 2022 Jan-Dec.
7
Glutathione in Brain Disorders and Aging.脑疾病和衰老中的谷胱甘肽。
Molecules. 2022 Jan 5;27(1):324. doi: 10.3390/molecules27010324.
8
Blood-Based Biomarkers for Glioma in the Context of Gliomagenesis: A Systematic Review.胶质瘤发生背景下基于血液的胶质瘤生物标志物:一项系统综述。
Front Oncol. 2021 Jun 4;11:665235. doi: 10.3389/fonc.2021.665235. eCollection 2021.
9
Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.循环 NADH 还原应激标志物与线粒体疾病严重程度相关。
J Clin Invest. 2021 Jan 19;131(2). doi: 10.1172/JCI136055.
10
Plasma Metabolome Profiling of Resistance Exercise and Endurance Exercise in Humans.人体抗阻运动与耐力运动的血浆代谢组学特征分析。
Cell Rep. 2020 Dec 29;33(13):108554. doi: 10.1016/j.celrep.2020.108554.